KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incyte (INCY) Current Deferred Revenue (2016)

Historic Current Deferred Revenue for Incyte (INCY) over the last 7 years, with Q3 2016 value amounting to $2.9 million.

  • Incyte's Current Deferred Revenue fell 7769.31% to $2.9 million in Q3 2016 from the same period last year, while for Sep 2016 it was $2.9 million, marking a year-over-year decrease of 7769.31%. This contributed to the annual value of $12.5 million for FY2015, which is 285.71% down from last year.
  • As of Q3 2016, Incyte's Current Deferred Revenue stood at $2.9 million, which was down 7769.31% from $6.1 million recorded in Q2 2016.
  • Incyte's 5-year Current Deferred Revenue high stood at $67.0 million for Q1 2012, and its period low was $2.9 million during Q3 2016.
  • Moreover, its 5-year median value for Current Deferred Revenue was $12.9 million (2014), whereas its average is $27.3 million.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first changed by 0.0% in 2012, then crashed by 8049.3% in 2013.
  • Quarter analysis of 5 years shows Incyte's Current Deferred Revenue stood at $66.1 million in 2012, then crashed by 80.49% to $12.9 million in 2013, then fell by 0.08% to $12.9 million in 2014, then decreased by 2.86% to $12.5 million in 2015, then tumbled by 77.08% to $2.9 million in 2016.
  • Its last three reported values are $2.9 million in Q3 2016, $6.1 million for Q2 2016, and $9.3 million during Q1 2016.